Phase 3 Immunization Clinical Trials
5 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–5 of 5 trials
Recruiting
Phase 3
Prevention of RSV Infection in Infants by Administering Nirsevimab to Infants, With or Without Maternal RSV Vaccination
RSV Immunization
Centre Hospitalier Annecy Genevois1,000 enrolled1 locationNCT07232706
Recruiting
Phase 3
Lot-to-lot Consistency Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From 2 Months of Age
Healthy VolunteersPneumococcal Immunization
Sanofi2,195 enrolled19 locationsNCT07348692
Recruiting
Phase 3
A Phase III Control Study of the Safety and Immunogenicity of vYF in Pediatric Population
Yellow Fever Immunization
Sanofi2,440 enrolled13 locationsNCT07103148
Recruiting
Phase 3
Study of the Safety of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age
Pneumococcal Immunization
Sanofi2,320 enrolled134 locationsNCT06824194
Recruiting
Phase 3
Clinical Study to Assess the Immunogenicity and Safety of Hexavalent Vaccine Containing Reduced Dose IPV
Diptheria ImmunizationTetanus ImmunizationPertussis Immunization+3 more
Serum Institute of India Pvt. Ltd.1,557 enrolled9 locationsNCT06413121